Answers are grounded in this paper and cite their sources.
Evaluation of weight-based and blood volume-based ferumoxytol doses improves vascular suppression in subjects, suggesting better dosing strategies.
Motivation: Ferumoxytol effectively suppresses vasculature in MR neurography, but the optimal dose is unknown. Goal(s): To determine the optimal dose by weight and blood volume. Approach: Thirty-two subjects were infused with varying Ferumoxytol doses (30 to 255 mg Fe) and underwent MR neurography at 3-Tesla; the vessel-to-muscle contrast ratio (CR) was measured. Results: Logarithmic regression improved with weight-based and volume-based doses (R²=0.443 to 0.613) versus the absolute dose (R²=0.362 to 0.499). 1.75-1.92 mg Fe/kg or 26.9-29.5 mg Fe/L doses were required to obtain CR<0.2, demonstrating that the subject weight/blood volume should be considered to optimize Ferumoxytol-based vascular suppression. Impact: Subject weight- or blood-volume-specific Ferumoxytol doses may provide effective vascular suppression for MR neurography evaluation of peripheral neuropathies like Parsonage Turner Syndrome (PTS), to reduce the dose and infusion time required.
No takes yet. Share an insight, caveat, or question.
Lowe et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: